Patent details

Basic Information

Publication number:

EP3658171

PCT Application Number:

EP2018069985

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP187435268

PCT Publication Number:

WO2019020599

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MULTI-EPITOPE FUSION PROTEIN OF AN HCV ANTIGEN AND USES THEREOF

French Title of Invention:

PROTÉINE DE FUSION À PLUSIEURS ÉPITOPES D'UN ANTIGÈNE DU VIRUS DE LE HÉPATITE C ET LEURS UTILISATIONS

German Title of Invention:

MULTI-EPITOP-FUSIONSPROTEIN EINES HCV-ANTIGENS UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

24/07/2018

Grant date:

30/08/2023

EP Publication Date:

03/06/2020

PCT Publication Date:

31/01/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/08/2023

EP B1 Publication Date:

30/08/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/07/2024

Expiration date:

24/07/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/08/2023

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

UPMEIER, Barbara

Address:

Germany (DE)

2

Name:

ZARNT, Toralf

Address:

Germany (DE)

3

Name:

BOLLHAGEN, Ralf

Address:

Germany (DE)

Priority

Priority Number:

17183523

Priority Date:

27/07/2017

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 38/16; G01N 33/576; C07K 19/00; C07K 14/18; C07K 14/005; G01N 33/569;

Publication

European Patent Bulletin

Issue number:

202335

Publication date:

30/08/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages